1046045-82-2

Upstream product

• 1046045-78-6 C₃₀H₂₅N₃S 
• 1046045-73-1 tert-butyl 4-(2-(2-propylpyridin-4-yl)thiazol-4-yl)phenylcarbamate 
• 1046045-58-2 4-[2-(2-propylpyridin-4-yl)-1,3-thiazol-4-yl]aniline 
• 125256-03-3 4-(4-(4-bromophenyl)thiazol-2-yl)-2-propylpyridine 
• 1046045-83-3 C₂₉H₃₈N₄O₃S 

Relevant academic research and scientific papers

COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS

The present invention relates to treatment and/or prevention of one or more metabolic disorders utilizing fatostatin A and/or a derivative and/or analog thereof. In other aspects, the compound for treatment and/or prevention of one or more metabolic disorders utilizes an A-B-C tripartite structure, wherein A, B, and C are identical or non-identical structures and are described in detail herein. In specific aspects, the metabolic disorder includes obesity or diabetes, for example.